CanAssist Breast (CAB), an immunohistochemistry (IHC) and artificial intelligence-based prognostic test, was developed on Hormone receptor-positive (HR +), HER2/neu-negative (HER2-) breast tumors from ...

Artificial intelligence is transforming breast cancer management through various machine learning applications. Artificial intelligence supports precision medicine by enhancing detection, diagnosis, ...

A risk model that combines a mammographic artificial intelligence (AI) risk score with polygenic and clinical risk scores ...

A groundbreaking artificial intelligence program that has received approval from the Food and Drug Administration (FDA) called Clairity Breast, may change the way doctors assess breast cancer risk ...

Ataraxis AI, a frontier artificial intelligence (AI) research lab developing AI-powered tools for oncology, today announced Ataraxis™ Breast CTX, a new predictive capability within its Ataraxis Breast ...

Clinicopathology-based machine learning model for prediction of pathologic complete response to neoadjuvant chemotherapy in breast cancer. This is an ASCO Meeting Abstract from the 2026 ASCO Annual ...

“As the first major randomized trial of AI in breast cancer screening in the U.S., this study represents a pivotal step,” said Jose Net, M.D., director of breast imaging services at Sylvester and ...

A small Venture Creations startup company is making big waves in the area of breast cancer detection. BiRed Imaging, co-founded in 2020 by RIT mechanical engineering professor Satish Kandlikar, blends ...

A new screening method that combines laser analysis with a type of AI is the first of its kind to identify patients in the earliest stage of breast cancer, a study suggests. A new screening method ...

Artificial intelligence helped spot breast cancers earlier and was linked to fewer dangerous cases emerging between routine screenings in a Swedish trial of more than 100,000 women. The findings ...

A new screening method that combines laser analysis with a type of AI is the first of its kind to identify patients in the earliest stage of breast cancer, a study suggests. The fast, non-invasive ...